FlowCardia
FlowCardia designs and develops catheter-based technologies for the treatment of totally occluded coronary and peripheral arteries.
Launch date
Market cap
-
Enterprise valuation
€73m (Public information from May 2010)
Sunnyvale California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$12.0m | Series B | ||
$30.0m | Series C | ||
$80.0m Valuation: $80.0m | Acquisition | ||
| Total Funding | €38.2m | ||